Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;11(2):100839.
doi: 10.1016/j.imr.2022.100839. Epub 2022 Feb 23.

Kampo medicines for supportive care of patients with cancer: A brief review

Yoshiharu Motoo  1 , Silke Cameron  2
Affiliations
Review

Kampo medicines for supportive care of patients with cancer: A brief review

Yoshiharu Motoo et al. Integr Med Res. 2022 Jun.

Abstract

Background: Kampo medicines, which are standardized traditional Japanese herbal medicines, have been tried to support patients with cancer.

Methods: Randomized controlled trials on the use of Kampo medicines for cancer supportive care and the descriptions of Kampo medicines in clinical practice guidelines were reviewed.

Results: Kampo medicines potentially ameliorate refractory symptoms in cancer patients. For example, hochuekkito, juzentaihoto, and ninjin'yoeito seem to be efficacious for fatigue/general malaise. Potential use of rikkunshito for anorexia/cancer cachexia and goshajinkigan for peripheral neuropathy is proposed from small numbers of randomized controlled trials in addition to basic research. The number of clinical practice guidelines which contain descriptions of Kampo medicines is increasing in general, but only a few in the area of cancer supportive care.

Conclusion: Kampo medicines potentially play some roles in preventing or ameliorating side effects of anticancer agents. Supportive care with Kampo medicines for patients with cancer might lead to physical, mental, and nutritional improvement.

Keywords: Anorexia; Cachexia; Cancer; Chemotherapy; Kampo; Supportive care.

PubMed Disclaimer

Conflict of interest statement

YM received honoraria from Tsumura & Co. The authors declare that this review was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. YM is an editorial board member of the journal but the editorial board membership had no bearing on the editorial process or decision.

Figures

Fig 1
Fig. 1
Historical aspects of cachexia in Japan.
Fig 2
Fig. 2
The top ten herbs (with asterisks; overlapped in two or three formulae) in three major “hozai”s and the seven herbs among them contained in rikkunshito (underlined).
Fig 3
Fig. 3
Regulation of ghrelin excretion and receptor expression by rikkunshito.
Fig 4
Fig. 4
What happens when cachexia sets-in?.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Motoo Y., Seki T., Tsutani K. Traditional Japanese medicine, Kampo: its history and current status. Chin J Integr Med. 2011;17(2):85–87. doi: 10.1007/s11655-011-0653-y. - DOI - PubMed
    1. Ohno T., Yanai M., Ando H., et al. Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol. 2011;4:291–296. doi: 10.2147/CEG.S26297. - DOI - PMC - PubMed
    1. Oteki T., Ishikawa A., Sasaki Y., et al. Effect of rikkunshi-to treatment on chemotherapy-induced appetite loss in patients with lung cancer: a prospective study. Exp Ther Med. 2016;11(1):243–246. - PMC - PubMed
    1. Ohnishi S., Watari H., Kanno M., et al. Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02) J Gynecol Oncol. 2017;28(5):e44. doi: 10.3802/jgo.2017.28.e44. - DOI - PMC - PubMed
    1. Harada T., Amano T., Ikari T., et al. Rikkunshito for preventing chemotherapy-induced nausea and vomiting in lung cancer patients: results from 2 prospective, randomized phase 2 trials. Front Pharmacol. 2018;8:972. doi: 10.3389/fphar.2017.00972. - DOI - PMC - PubMed

LinkOut - more resources